Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.

General Discussions

Jennifer Wenzel on Prioritizing Representation in Clinical Trials

By Jennifer Wenzel, PhD, RN, CCM, FAAN
PUBLISHED WEDNESDAY, DECEMBER 31, 1969


Jennifer Wenzel, PhD, RN, CCM, FAAN, of Johns Hopkins University School of Medicine, discusses why representation in clinical trials is not successful as an afterthought.

As funding for research gets tighter, there are less programs to ensure diversity in research – these are often the first programs to be cut when money is short. In response, nurses can advocate for funding and policies which allow for research promoting diversity. The only way to be sure that clinical trials have adequate representation is to make it a priority within research planning.
Start a discussion
You must log in to use this feature, please click here to login.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.